#Stomach Gastric Cancer surgery cost in India

[enhertu]

All about Enhertu

ENHERTU: AVAILABILITY IN INDIA Trastuzumab deruxtecan is a potent cancer drug sold under the name Enhertu It is an efficient drug that is used in the treatment of various sorts of cancers by inhibiting an enzyme called topoisomerase. It treats human epidermal growth factor receptor 2 (HER2)-positive breast cancer, which is metastatic and cannot be removed by surgery, and Gastric or gastroesophageal junction (GEJ) adenocarcinoma has spread locally to parts near the stomach or in other body parts. It is an FDA-approved drug available in India against a valid prescription. You can also buy Enhertu online in India through authorized dealers recognized for doing that. Ikris Pharma Networks are among those trusted suppliers.

EFFECT ON INTERSTITIAL LUNG DISEASE Enhertu can actively cause interstitial lung disease and worsen it. Interstitial lung disease (ILD) and pneumonitis, including fatal cases, have been reported with ENHERTU. During treatment, monitoring should be done and promptly investigate signs and symptoms, including cough, dyspnea, fever, and other new or worsening respiratory symptoms. ENHERTU should be permanently discontinued in all patients with Grade 2 or higher ILD/pneumonitis. It is advised for patients at risk to report symptoms immediately. To know more about the drug and its cost, you can visit us at Contact us: Ikris Pharma Network | Toll-Free:- 1800 889 1064. The drug is proven of great use when used under expert medical specialists and Enhertu cost in India is reasonable and budget-friendly, so it can be easily used.

DOSAGE AND ADMINISTRATION Enhertu is meant to be used intravenously only. It comes in ENHERTU 100 mg lyophilized powder in a single-dose vial. It is not meant to substitute for or with trastuzumab or ado-trastuzumab emtansine. During the treatment of metastatic breast cancer, the recommended dose for ENHERTU is 5.4 mg/Kg, which is given in the vein by dripping once every 3 weeks, and the recommended dose of ENHERTU for Locally Advanced or Metastatic gastric cancer is 6.4 mg/kg, the same as breast cancer. The drug should be continued until it is ineffective and the disease progresses. ENHERTU can cause various adverse drug effects, including ILD, neutropenia, thrombocytopenia, or left ventricular dysfunction. In these cases, symptoms should be monitored carefully, and in case of hypersensitivity, the drug should be moderated or discontinued as required. ENHERTU 100 mg injection cost is economical, and against a valid prescription, it can be bought from various recognized platforms.

BENEFITS An ongoing study has found that ENHERTU has resulted in shrinking the tumor of patients with metastatic breast cancer and locally or advanced metastatic gastric carcinoma that could not be removed by surgery. The patients survived way more time than it was predicted, which makes ENHERTU a savior for patients with breast or gastric cancer. If a recommended dose with appropriate treatment as prescribed by the respective cancer specialist is taken, it is considered one of the most reliable drugs; that's why on August 5, 2022, the FDA approved fam-trastuzumab deruxtecan-nxki (brand name ENHERTU) for adult patients with unresectable or metastatic HER2-low breast cancer. You can also buy ENHERTU injection online. Only a valid prescription with some other formalities is required. You can contact us to check for the details; we will be happy to help.

SIDE EFFECTS The most common adverse effects of Enhertu, which may affect more than 1 in 5 people, are nausea, tiredness, vomiting, alopecia (hair loss), constipation, decreased appetite, anemia (low levels of red blood cells), neutropenia (low levels of neutrophils, a type of white blood cell that fights infection), diarrhea, muscle, and bone pain, increased levels of certain liver enzymes (transaminases), thrombocytopenia (low levels of blood platelets, which can lead to bleeding and bruising) and leukopenia (low levels of white blood cells). ENHERTU is made available in India so that needy patients can purchase it at pocket-friendly rates. ENHERTU price is budget efficient and can easily be incorporated as part of treatment, recommended by cancer experts.

DESCRIPTION enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate. Being an efficient drug, it's in so much demand. It is given by dripping in a vein, and ENHERTU injection cost is economical. Fam-trastuzumab derux tecan-ki, which is an active ingredient in enhertu , is an antibody-drug conjugate (ADC). It is a humanized anti-HER2 IgG1 monoclonal antibody (mAb) linked covalently to a topoisomerase inhibitor with a tetrapeptide-based cleavable linker. Deruxtecan has a protease-cleavable maleimide tetrapeptide linker and a topoisomerase inhibitor. With the help of recombinant DNA technology, the antibody is produced in Chinese hamster ovary cells. The topoisomerase inhibitor and linker are synthesized chemically. 8 molecules of deruxtecan are attached to each antibody molecule approximately. enhertu is a sterile, white to yellowish-white, preservative-free lyophilized powder in single-dose vials. Each vial has 100 mg of fam-trastuzumab deruxtecan-nxki, L-histidine (4.45 mg), L-histidine hydrochloride monohydrate (20.2 mg), polysorbate 80 (1.5 mg), and sucrose (450 mg). It is reconstituted with 5 mL of Sterile Water for Injection, USP, and the resulting concentration of trastuzumab is 20 mg/mL with a pH of 5.5. The resulting solution is given intravenously. To know more about enhertu injection cost

#EnhertupriceinIndia

#EnhertuinIndia

#Enhertu100mgprice

[indiacancersurgerysite]

Get Free Consultation About Cancer Treatment In India From Our Top Medical Experts You Can Call At +91 9371770341 Or You Can Fill Our Free Consultation Form  : https://bit.ly/2N6jiC2

[francesmays]

The Best Stomach Cancer Oncologist in Mumbai and Top Cancer Hospitals Are A Click Way

What Is Stomach Cancer? Before we talk about the stomach top hospital in Mumbai India, we need to understand the ailment first. Well, the stomach cancers can be seen developing slowly and gradually over several years. Before you see a true cancer developing, the pre-cancerous changes are seen occurring in the inner lining (mucosa) of the stomach. These can be called as the early changes that are…

[jdrsandeep]

Top Rated Gallbladder, Laparoscopic & Bariatric Surgeon In Jaipur

Dr. Sundeep Jain is an Indian surgeon based in India who leads a team of surgeons and doctors. He has done extensive research on gallbladder cancer surgery, which causes the most deaths from surgery in India. In this article, he discusses laparoscopic and bariatric surgeries that can be done for gallbladder cancer patients for a better outcome.

Dr. Sundeep Jain is a foremost expert in Gallbladder Cancer Surgery in India; he has been conducting laparoscopic and bariatric operations for many years now and making it possible for his patients to have a better living quality with much fewer complications than those seen before.

His surgical skills enable him to organize skilled teams that can offer more effective healthcare options to patients around the world while reducing the cost of medical care by 70%.“I've got these awesome nurses,” he said. “They have done a lot of stuff on their own, but I got them organized. We now have standardized protocols that are followed to the letter for every patient that comes through the door. Now it's all about what type of procedure we want. What does the patient need? Can we get the patient ready for what they need?" Every day we are evolving and getting better. "The new facility, which is less than a year old, has not only helped the hospital improve their care, but it has also made health-care possible in a much more convenient manner.

What is Gallbladder Cancer?

Gallbladder cancer is a common ailment that occurs when a substance called bile accumulates in the gallbladder by the tumor and causes inflammation.

A surgeon who holds a bachelor’s degree in surgical technology and a master’s degree in public health, Dr. Sundeep Jain has been named among the top 10 surgeons in India. Sharing his experiences with gallbladder cancer surgery, Dr. Sundeep Jain shares his perspective on what makes for an effective surgical procedure in India.

Recently, we have seen the emergence of new techniques for gallbladder surgery with laparoscopic and bariatric options available to physicians who are seeking to help their patients recover more quickly. At Whipples Surgery Services, we offer expertise in laparoscopic and bariatric surgeries as

At Whipples Surgery Services, we provide expert services in laparoscopic and bariatric surgeries. Our surgeons are highly experienced, have many years of surgical experience, and have come from the best medical schools in the country. We offer competitive prices for our services with an affordable payment plan that is convenient for our patients.

Overview of Gallbladder Cancer Treatment Options

Dr. Sundeep Jain is a laparoscopic and Bariatric Surgeon in India who has conducted a lot of gallbladder surgery in India. In this article, he explains various treatment options for these patients with Gallbladder Cancer and the pros and cons of each option.

Surgery is the only cure for Gallbladder Cancer. If a patient is diagnosed with this condition in India, they may be advised surgery by their doctor to remove it through the keyhole or open surgery.

The surgery can be done by laparoscopic or open methods. There are many drawbacks associated with both of these procedures such as infection, blood loss, and bowel ulceration. Recent advances in medical technology have led to many new minimally invasive surgical techniques. These procedures typically require little or no incision and often lead to faster recovery times and reduced pain levels. One of the most common minimally invasive procedures is the laparoscopic Roux-en-Y gastric bypass (LRYGB) procedure. The LRYGB procedure is a common weight loss surgery that involves creating a small incision near the belly button and then inserting two tubes into the abdomen. A bariatric surgeon will create an opening in the stomach and create an outlet for food to pass through out of order.

What is the Best Option for You?- Getting an idea of what procedure to opt for

Dr. Sundeep Jain is an experienced and well-regarded surgeon from India. In this article, he talks about the surgical procedure and the best option for you.

The first step in deciding on the best option for you is getting a thorough evaluation from your doctor to find out what's causing your gallstones, or if there are any other factors that may make surgery more difficult for you such as your age, smoking, etc.

Laparoscopic Surgical Options- The Complete Guide to Laparoscopy & How it Yields Better Results with Less Pain & Discomfort

Dr. Sundeep Jain is one of the most experienced surgeons in India for Gallbladder cancer surgery. He has been providing surgical services to patients and providing innovative alternatives to minimally invasive surgeries.

Dr. Sundeep Jain is considered one of the best in the field of surgical procedures. He recently published a book called "The Complete Guide to Laparoscopy & How it Yields Better Results with Less Pain & Discomfort." This book has a plethora of information about different surgical options for Gallbladder cancer, Laparoscopic and Bariatric surgeries, Whipple's surgery, and RNY procedures, among others.

While laparoscopic surgery provides patients with a small incision in their abdomen, it also provides them with quicker recovery times along with less pain and discomfort. Laparoscopic Surgeon in India is also more cost-efficient, meaning the cost for a patient and the return for the hospital are cheaper than open surgery. A press release from U.S. News states, "Patients undergoing laparoscopic adhesiolysis have reduced pain and disability compared with those who undergo open surgery."

[hazel51]

Gastric Sleeve Surgery is also well known for weight loss surgery

Gastric sleeve surgery is a type of bariatric surgery/weight loss surgery. It is a type of bariatric surgery that involves removal of the outer two-thirds of the stomach so that the person feels full even after eating a small amount of food. Unlike a bypass surgery, sleeve gastrectomy does not interfere with the normal digestive procedure. Like other bariatric surgery procedures, sleeve gastrectomy ( also known as vertical sleeve, gastric sleeve, or tube gastrectomy) is now covered by insurance. Obesity and Metabolic Surgery Society of India (OSSI) has defined obesity as a disease and not a lifestyle disorder.

Want professional consultation? Dr Aparna Govil Bhasker is one of  gastric sleeve surgery in mumbai

What is gastric sleeve surgery?

It is a surgical procedure in which outer two-third of the stomach is divided surgically and removed. This leads to formation of a long and narrow tube of the stomach. Post gastric sleeve surgery, appetite is reduced, as is the capacity to eat. Eventually it leads to increased insulin sensitivity which in turn leads to healthier and fitter life.

How does vertical sleeve gastrectomy help?

The benefits are not limited to just losing weight; it reduces the risk of many life threatening diseases and conditions such as

Type 2 diabetes

Heart disease and high blood pressure

Stroke

Cancer

Infertility

Obstructive sleep apnea

Indications for Gastric Sleeve

Bariatric/metabolic surgery should be considered a treatment option for acceptable Indian patients with a BMI ≥ 35 kg/m2, with/without presence of any obesity related co-morbidity.

Bariatric/metabolic surgery should be considered a treatment option for acceptable Indian patients with a BMI ≥ 30 kg/m2, in presence of two or more obesity related comorbidities.

Bariatric/metabolic surgery should be considered as a non-primary treatment option for acceptable Indian patients with a BMI ≥ 27.5 kg/m2, with uncontrolled type 2 diabetes despite optimum medical management.

Any bariatric/metabolic surgery for an Indian patient with BMI < 27.5 kg/m2 should be strictly performed under experimental study protocol with prior ethics committee approval and informed consent from the patient.

Bariatric/metabolic surgery should be considered as a treatment option for acceptable Indian patients with central obesity with a waist circumference ≥ 80 cm in females and ≥ 90 cm in males along with type two diabetes and other obesity related co-morbidities.

Bariatric/metabolic surgery may be advised as a treatment option for acceptable Indian patients who qualify for the above BMI criteria if they are ≥ 18 years of age. It may be advised as a treatment option to patients younger than 18 years of age under special circumstances with approval of a multi-disciplinary team constituting a paediatrician, endocrinologist, dietician, psychologist and the bariatric team including a bariatric surgeon. Attainment of puberty and completion of skeletal maturity must be taken into account for this patient population when considering the option of surgery.

Bariatric/metabolic surgery should be advised as a treatment option for acceptable Indian patients who qualify for the above BMI criteria for patients up to 65 years of age. Bariatric/metabolic surgery may also be recommended for patients ≥ 65 years of age if they are medically fit, and the benefits of surgery outweigh the risks.

All patients who are advised bariatric/metabolic surgery as a treatment option should be motivated to enter a long-term weight management program and should be committed to life-long follow up.

Curious about Gastric Sleeve surgery Cost in mumbai? Follow the link to get more information on Gastric Sleeve surgery.

Vertical sleeve surgery requires a life time of dedication to stick to a healthy diet and exercise

You need the best team of doctors and surgeons, dieticians, and exercise trainers to work with you after a gastric sleeve surgery. The dietician will give a documented guide on how much to eat after the sleeve surgery, and the trainer will help you get more active and make a workout program that you can easily stick to.

Modern gastric sleeve surgery is done using a laparoscopy which makes it a minimally invasive procedure with quick recovery times and fewer complications. You will back to regular life within 7 to 10 days of the surgery.

Things to keep in mind post sleeve gastrectomy surgery mumbai:

Eat at a slow place. If you eat too much and too fast you might get a choking sensation or feel like vomiting.

Nausea is common for a few weeks after surgery

You need to maintain a healthy diet and make sure that you intake a balance of vitamins and minerals like iron, vitamin, B12, folate, vitamin D, protein etc.

You will continue to lose weight for months after the vertical sleeve surgery before it stabilizes to a normal weight.

[clevertimetravelpaper]

Gastric Cancer Drug Market Global Key Players, Market Dynamics, Future Demand Analysis and Forecasts To 2028

The gastric cancer drug market is expected to witness market growth at a rate of 14.95% in the forecast period of 2021 to 2028. Data Bridge Market Research report on gastric cancer drug market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The increase in the prevalence of gastric cancer globally is escalating the growth of gastric cancer drug market.

Gastric cancer is also referred to as stomach cancer which is a type of cancer that begins when the cancer cells form in the inner lining of the stomach. This cancer generally progresses slowly. Indigestion, heartburn, slight nausea and loss of appetite among others are considered some of the early symptoms of this cancer. As the tumor progresses, the symptoms get worse such as vomiting, yellowish eyes or skin, stomach pain, swelling in stomach, weight loss, constipation and blood in stool.

Get a Sample PDF of the report – https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-gastric-cancer-drug-market

Gastric Cancer Drug Market Scope and Market Size

The gastric cancer drug market is segmented on the basis of type, treatment type, drug type, route of administration and end- users. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. 

On the basis of type, the gastric cancer drug market is segmented into adenocarcinoma, lymphoma, gastrointestinal stromal tumor, carcinoid tumor and others.

On the basis of treatment type, the gastric cancer drug market is segmented into chemotherapy, targeted therapy, immunotherapy, surgery, radiation therapy, medication and others.

On the basis of drug type, the gastric cancer drug market is segmented into doxorubicin hydrochloride, sunitinib mitomycin, imatinib, fluorouracil, trastuzumab and others.

On the basis of route of administration, the gastric cancer drug market is segmented into oral and injectable.

On the basis of end- users, the gastric cancer drug market is segmented into hospitals, homecare, specialty clinics and others.

To Gain More Insights into the Market Analysis, Browse Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-gastric-cancer-drug-market

Global Gastric Cancer Drug Market Country Level Analysis

The gastric cancer drug market is analyzed and market size insights and trends are provided by country, type, treatment type, drug type, route of administration and end-users as referenced above.      

The countries covered in the global gastric cancer drug market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the gastric cancer drug market due to the rising prevalence of stomach cancer and the availability of advanced technology in cancer research and treatment centers.

The country section of the gastric cancer drug market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Gastric Cancer Drug Market Share Analysis

The gastric cancer drug market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to gastric cancer drug market.

The major players covered in the gastric cancer drug market report are mugene Limited, Otsuka Pharmaceuticals Co., Ltd, Immutep, F. Hoffmann-La Roche Ltd, Merck KGaA, Bristol-Myers Squibb Company, Novartis AG, Eli Lilly and Company, Sanofi S.A, Amgen Inc., Bayer AG, Celgene Corporation, Gilead Sciences, Inc., AstraZeneca, Ipsen Pharma, Takeda Pharmaceutical Company Limited, Samumed, LLC, Arbutus Biopharma, ASLAN Pharmaceuticals among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Browse the complete table of contents at  https://www.databridgemarketresearch.com/toc/?dbmr=global-gastric-cancer-drug-market

Related Reports: 

North America Laboratory Hoods and Enclosure Market- Size, Shares, Trends and Industry Growth Outlook  https://www.databridgemarketresearch.com/reports/north-america-laboratory-hoods-and-enclosure-market

North America Biosurgery Market- Size, Shares, Trends and Industry Growth Outlook https://www.databridgemarketresearch.com/reports/north-america-biosurgery-market

Europe Biosurgery Market- Size, Shares, Trends and Industry Growth Outlook https://www.databridgemarketresearch.com/reports/europe-biosurgery-market

Asia-Pacific Biosurgery Market- Size, Shares, Trends and Industry Growth Outlook https://www.databridgemarketresearch.com/reports/asia-pacific-biosurgery-market

Pressure Guidewires Market- Size, Shares, Trends and Industry Growth Outlook https://www.databridgemarketresearch.com/reports/global-pressure-guidewires-market

Nephrostomy Guidewires Market- Size, Shares, Trends and Industry Growth Outlook https://www.databridgemarketresearch.com/reports/global-nephrostomy-guidewires-market

Cardiac Guidewires Market- Size, Shares, Trends and Industry Growth Outlook https://www.databridgemarketresearch.com/reports/global-cardiac-guidewires-market

Introducer Sheaths and Guidewires Market – Size, Shares, Trends and Industry Growth Outlook   https://www.databridgemarketresearch.com/reports/global-introducer-sheaths-and-guidewires-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:- corporatesales@databridgemarketresearch.com

[alafiyameditourindia]

Stomach cancer treatment India Stomach or gastric cancer occurs when some stomach cells grow out of control. Cancer usually starts in the inner stomach lining before penetrating deeper. Gastric cancer cases in India are lower than in many countries.

https://www.alafiyameditour.com/treatment/stomach-cancer/

[drsundeepjain]

The Best Esophagus Cancer Treatment Centers in India

Every year, there are more than 1.6 million people diagnosed with cancer in India. It is critical to understand the best treatment centers for your cancer type and geographical location. - Hernia Surgery Jaipur

Choosing the best esophagus cancer treatment centers in India is not an easy job for most patients. A lot of factors come into play when choosing a treatment center like doctor's expertise, hospital facilities, and cost-effectiveness of the surgery.

Introduction: What is Esophagus Cancer and What are the Causes?

Esophagus Cancer is a tumor that starts in the esophagus, also known as the food pipe or wind pipe. It is usually caused by excessive smoking, alcohol consumption, and chemical ingestion.

What is Esophagus Cancer?

Esophagus cancer is a tumor that starts in the esophagus. This organ is responsible for transporting food from the mouth to the stomach.

The causes of this dangerous disease are: excessive smoking, alcohol consumption, and chemical ingestion in some cases. It can also be caused by family genetic disorders like hereditary diffuse gastric cancer syndrome and Li-Fraumeni syndrome.

Different Types of Surgery for Esophageal Cancer

As a result of the advances in surgical technology, esophagus cancer is now one of the most curable cancers. It can be treated with surgery and a few other procedures. Oncologists at the leading hospitals in India are equipped with latest equipment to detect and diagnose this type of cancer quickly and effectively.

Different Types of Surgery for Esophageal Cancer:

-Surgery to remove esophageal cancer growths or tumors

-Surgery to treat or remove obstructions if acid is backing up into the food pipe (a condition called reflux)

-Surgery to improve air flow across the vocal cords and lungs if you have difficulty breathing or swallowing

-Surmission to remove part of your stomach if you have an ulcer due to chronic irritation from stomach acid

What to Expect from the Recovery Process and How to Approach it?

A patient is required to have a liver cancer surgery in Jaipur for the complete removal of their tumor. After surgery, a patient may need to stay in the hospital for a few days and will be monitored by doctors and nurses. The recovery process may take as long as two weeks depending on individual’s condition and previous medical history. Hence, following steps should be taken to recover from the surgery:

- The person should not lift anything heavy such as furniture or even small objects like pencils; instead they should just sit up in bed or on a chair once in while.

- A person should not consume any alcoholic drinks like wine or beer because it will slow down their recovery process; instead they can drink fruit juices which are rich with nutrients and minerals.

For More Info: Gallbladder cancer surgery in India Laparoscopic Surgeon in India

Whipples Surgery in Jaipur

[decisionforsight]

Global Gastric Cancer Drugs Market

Global Gastric Cancer Drugs Market Size, Share, Growth, Industry Trends and Forecast 2020-2030

Gastric cancer is the formation of abnormal cells on the inner lining of stomach resulting into stomach tumors. Additionally, Gastric cancer is also known as stomach cancer and gastric cancer drugs are used to treat malignancies or cancerous cells growth. The global gastric cancer drugs market accounted approximate USD 3.6 billion in 2020 and it is expected to reach USD 13.3 billion by 2030 with a CAGR of 13.80% during forecast period. According to report it is identified that gastric cancer was responsible for fourth most common malignancy occur in men and seventh rank in women. Additionally, treatment cancer is depends upon the stage of cancer and there are number of treatments available for the cancer such as chemo therapy, radiation therapy, surgery and others.

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020190

Market Dynamics and Factors:

Rising incidence and prevalence rate of gastric cancer are boosting the global gastric cancer drugs market. Moreover, increasing in R&D studies and clinical trials to understand stomach cancer better and to develop medicine are highly contributing to the gastric cancer drugs market revenue. Additionally, increase in smoking population, obesity cases, consuming tobacco, unhealthy diet lifestyles resulting into the increase in number of cases in gastric cancer will drive the growth for gastric cancer drug market. However, high cost involved in the treatment and side effects due to prolonged use of cancer drugs hinders the growth of market. Moreover, the development of innovative drugs and rising awareness about these treatments among the consumers can be opportunity for the gastric cancer drugs market.

Market Segmentation:

Global Gastric Cancer Drugs Market – By Therapy Type

Kinase Inhibitors

Nucleoside Metabolic Inhibitors

Microtubule Inhibitors

VEGF Antibodies

Her2 Receptor Antagonists

Car T Cell Therapy

Global Gastric Cancer Drugs Market – By Route of Administration

Oral

Parenteral

Global Gastric Cancer Drugs Market – By Application

Adenocarcinomas

Gastrointestinal Stromal Tumors

Carcinoid Tumors

Global Gastric Cancer Drugs Market – By End-User

Hospital

Retail Pharmacy

Online Pharmacy

Global Gastric Cancer Drugs Market – By Geography

North America

U.S.

Canada

Mexico

Europe

U.K.

France

Germany

Italy

Rest of Europe

Asia-Pacific

Japan

China

India

Australia

Rest of Asia Pacific

ROW

Latin America

Middle East

Africa

New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020190

Geographic Analysis:

North America is dominating the gastric cancer drugs market and is anticipated to maintain same trend during the forecast period. According to research study, guidelines of medicines regulatory agencies in the region are driving the market. Moreover, availability of better medical infrastructure, increase in R&D, availability of drug development therapies in the region driving the market for gastric cancer drugs. Asia Pacific is anticipated to witness fastest growth and is expected maintain same trend during forecast period. According, to research report the region generated approximate USD 1.12 billion revenue in 2018. Rise in incidences of gastric cancer in the region primarily in India and China are driving the growth of market. The World Health Organization (WHO) estimates that China accounted approximate 456,124 gastric cancer cases in 2018.

Competitive Scenario:

Some of the key players in global gastric cancer drugs market are F. Hoffmann-La Roche ltd., Novartis A.G., Eli Lily and company, Sanofi S.A., Bayer A.G., Otsuka pharmaceuticals co.Ltd., Gilead Sciences Inc., Celltrion Inc., Taiho pharmaceuticals co. ltd, and Merck & co. Inc.

Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020190 

How will this Market Intelligence Report Benefit You?

The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.

Exclusive insight into the key trends affecting the Global Gastric Cancer Drugs industry, although key threats, opportunities and disruptive technologies that could shape the Global Gastric Cancer Drugs Market supply and demand.

The report tracks the leading market players that will shape and impact the Global Gastric Cancer Drugs Market most.

The data analysis present in the Global Gastric Cancer Drugs Market report is based on the combination of both primary and secondary resources.

The report helps you to understand the real effects of key market drivers or retainers on Global Gastric Cancer Drugs Market business.

The 2021 Annual Global Gastric Cancer Drugs Market offers:

100+ charts exploring and analysing the Global Gastric Cancer Drugs Market from critical angles including retail forecasts, consumer demand, production and more

15+ profiles of top producing states, with highlights of market conditions and retail trends

Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand

Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Gastric Cancer Drugs Market type

Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020190 

About Us:

Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.

Contact:

Email: sales@decisionforesight.com

For Latest Update Follow Us:

https://www.facebook.com/Decision-Foresight-110793387201935

https://twitter.com/DecisionFs

https://www.linkedin.com/company/decision-foresight/

[indiamedicaltourism]

Stomach Cancer Treatment Cost in India

The stomach is an abdominal muscle situated in the upper portion of the abdomen, which plays an important function in the breakdown of food. It gathers food from the oesophagus, decreases, and combines it with other digestive juices to break down the food into smaller molecules that may be digested in the smaller intestine.

A tumor that begins from the stomach wall is stomach cancer, also referred to as gastric cancer. Although this kind of cancer is rare, it can be extremely dangerous and often found at a terminal stage, rendering treatment tougher.

Different types of methods are often used to treat stomach cancer, and the exact treatment method varies depending on the disease stage, the patient's overall well-being, and the extent and location of the tumor. Surgery, radiation therapy, and chemotherapy are all possible methods of treatment for stomach cancer.

To create a personalized treatment strategy for each patient with stomach cancer, it's necessary that they interact closely with an organization of physicians consisting of cancer specialists, doctors, and other experts. Regular check-ups and tumor screenings are required for all individuals, but especially for those who have risk factors, including a family connection to the condition or an earlier episode of infection with Helicobacter pylori. Early recognition is important in determining your odds for stomach cancer.

Stomach Cancer Treatment Cost in India

Similar to other economies, Stomach Cancer Treatment  cost in India varies according to a number of factors. Treatment expenses for stomach cancer fluctuate by both clinical and not medical variables. Approximately Rs. 2,50,000 to Rs. 4,50,000 is the common cost of Stomach Cancer Treatment in India. Compared with several other nations, the price of Stomach Cancer Treatment in India is much less expensive. This is because of a wide variety of both private and public facilities in India that offer inexpensive, elite medical treatment. Also, India makes most of the medications and supplies necessary for treating stomach cancer domestically, which lowers the expense of importing them from other countries.

Best Stomach Cancer Treatment Hospitals in India

India is making major improvements in the area of medicine, especially in the identification, administration, and treatment of cancer patients. Since cancer is growing more common, there is an increasing demand for cancer hospitals with advanced treatment options. The best Stomach Cancer Treatment hospital in India provides finest cancer treatment at affordable prices and has an extensive network that can accommodate patients from various locations and are appreciated greatly. They adhere with accreditations, qualifications, and quality- and safety-related standards. Apollo Cancer Institute, Rajiv Gandhi Cancer Institute and Research Centre and Kidwai Memorial Institute of Oncology are some of the best hospital for Stomach Cancer Treatment in India

Best Stomach Cancer Treatment Doctors in India

The Best Stomach Cancer Treatment doctors in India are highly qualified and are experienced group of physicians and surgeons that specialise in curing stomach cancer. Some of the Best Doctors for Stomach Cancer Treatment in India are:

Dr.SandeepBatra

Dr.AnkurBahl

Dr. Deepak Govil

Al Afiya Medi Tour is a leading medical tourism company in India. We are offer medical tourism services in India foreign patients. Some of the main countries are Bangladesh, South Africa, Uganda, Zambia, Namibia, Iraq, Kenya, Ethiopia, Nigeria, and so on. We provide free assistance for TURP surgery cost, lung cancer treatment, breast cancer surgery, stomach cancer treatment, ovarian cancer treatment, liver transplant cost, best hospital for heart valve replacement, liver cancer treatment, bone marrow transplant cost,prostate cancer treatment, arthroscopic surgery, best liver transplant hospital, brain tumor surgery, kidney transplant, cancer treatment, liver transplant treatment, leukemia treatment, best bone marrow hospital, etc.  If you are searching for free medical and healthcare consulting to find the best hospitals and top doctors and surgeons in India for any treatment then contact us- Alafiyameditour.com.

Source: https://alafiyameditour1.blogspot.com/2023/09/stomach-cancer-treatment-cost-in-india.html

[lisa36resnick]

Cancer Treatment in India,Top cancer surgeons of India,Top Hospitals for cancer surgery in India,Budget price cancer treatment in India 

[jdrsandeep]

Dr. Sundeep Jain, Gallbladder Cancer Surgery in India, Laparoscopic and Bariatric Surgeon

Dr. Sundeep Jain is an Indian surgeon based in India who leads a team of surgeons and doctors. He has done extensive research on gallbladder cancer surgery, which causes the most deaths from surgery in India. In this article, he discusses laparoscopic and bariatric surgeries that can be done for gallbladder cancer patients for a better outcome.

Dr. Sundeep Jain is a foremost expert in Gallbladder Cancer Surgery in India; he has been conducting laparoscopic and bariatric operations for many years now and making it possible for his patients to have a better living quality with much fewer complications than those seen before.

His surgical skills enable him to organize skilled teams that can offer more effective healthcare options to patients around the world while reducing the cost of medical care by 70%.“I've got these awesome nurses,” he said. “They have done a lot of stuff on their own, but I got them organized. We now have standardized protocols that are followed to the letter for every patient that comes through the door. Now it's all about what type of procedure do we want? What does the patient need? Can we get the patient ready for what they need?" Every day we are evolving and getting better. "The new facility, which is less than a year old, has not only helped the hospital improve their care, but it has also made health-care possible in a much more convenient manner.

What is Gallbladder Cancer?

Gallbladder cancer is a common ailment that occurs when a substance called bile accumulates in the gallbladder by the tumor and causes inflammation.

A surgeon who holds a bachelor’s degree in surgical technology and a master’s degree in public health, Dr. Sundeep Jain has been named among the top 10 surgeons in India. Sharing his experiences with gallbladder cancer surgery, Dr. Sundeep Jain shares his perspective on what makes for an effective surgical procedure in India.

Recently, we have seen the emergence of new techniques for gallbladder surgery with laparoscopic and bariatric options available to physicians who are seeking to help their patients recover more quickly. At Whipples Surgery Services, we offer expertise in laparoscopic and bariatric surgeries as

At Whipples Surgery Services, we provide expert services in laparoscopic and bariatric surgeries. Our surgeons are highly experienced, have many years of surgical experience, and have come from the best medical schools in the country. We offer competitive prices for our services with an affordable payment plan that is convenient for our patients.

Overview of Gallbladder Cancer Treatment Options

Dr. Sundeep Jain is a laparoscopic and bariatric surgeon who has conducted a lot of gallbladder surgery in India. In this article, he explains various treatment options for these patients with Gallbladder Cancer and the pros and cons of each option.

Surgery is the only cure for Gallbladder Cancer. If a patient is diagnosed with this condition in India, they may be advised surgery by their doctor to remove it through the keyhole or open surgery.

The surgery can be done by laparoscopic or open methods. There are many drawbacks associated with both of these procedures such as infection, blood loss, and bowel ulceration. Recent advances in medical technology have led to many new minimally invasive surgical techniques. These procedures typically require little or no incision and often lead to faster recovery times and reduced pain levels. One of the most common minimally invasive procedures is the laparoscopic Roux-en-Y gastric bypass (LRYGB) procedure. The LRYGB procedure is a common weight loss surgery that involves creating a small incision near the belly button and then inserting two tubes into the abdomen. A bariatric surgeon will create an opening in the stomach and create an outlet for food to pass through out of order.

What is the Best Option for You?- Getting an idea of what procedure to opt for

Dr. Sundeep Jain is an experienced and well-regarded surgeon from India. In this article, he talks about the surgical procedure and the best option for you.

The first step in deciding on the best option for you is getting a thorough evaluation from your doctor to find out what's causing your gallstones, or if there are any other factors that may make surgery more difficult for you such as your age, smoking, etc.

Laparoscopic Surgical Options- The Complete Guide to Laparoscopy & How it Yields Better Results with Less Pain & Discomfort

Dr. Sundeep Jain is one of the most experienced surgeons in India for Gallbladder cancer surgery. He has been providing surgical services to patients and providing innovative alternatives to minimally invasive surgeries.

Dr. Sundeep Jain is considered one of the best in the field of surgical procedures. He recently published a book called "The Complete Guide to Laparoscopy & How it Yields Better Results with Less Pain & Discomfort." This book has a plethora of information about different surgical options for Gallbladder cancer, Laparoscopic and Bariatric surgeries, Whipple's surgery, and RNY procedures, among others.

While laparoscopic surgery provides patients with a small incision in their abdomen, it also provides them with quicker recovery times along with less pain and discomfort. Laparoscopic surgery is also more cost-efficient, meaning the cost for a patient and the return for the hospital are cheaper than open surgery. A press release from U.S. News states, "Patients undergoing laparoscopic adhesiolysis have reduced pain and disability compared with those who undergo open surgery."

[obesitycare]

How much does Bariatric Surgery Cost in India?

Obesity has reached epidemic proportions. People who are severely obese face a great challenge in losing weight. Measures taken for losing weight like exercise, through dietary restriction and medicines usually don’t work in such cases. Also, studies show that these non-surgical treatment of severe obesity does not lead to any meaningful weight loss. 85-90% of patients gain back the weight they have lost. Hence, surgery is the only effective solution for sustained and significant weight loss. It does not only lead to significant and sustainable weigh loss but also helps in resolution of disease associated with obesity that included diabetes, sleep apnea, hypertension and osteoarthritis. After bariatric, total long-term mortality is significantly reduced, typically death from cancer, heart disease and diabetes. The obesity cases have been increasing majorly in India with more than 40,000 bariatric surgeries are carried out in the nation every year.  

 WHAT IS BARIATRIC SURGERY?

 Bariatric surgery is not same as liposuction which include any removal of fat. This should not be the concept on your head. It involves working and operating on the stomach or besides the bypass of a portion of a small intestine in order to form caloric limit as well as malabsorption.  The 3 main operations for the treatment of obesity are: Roux-En-Y Gastric Bypass (RYGBP), Sleeve Gastrectomy (SG) and Adjustable Gastric Banding (AGB).

 The surgeries are performed out laparoscopically. Normally, there are two 5mm and three 1 cm slits on the surface of the skin. The patient usually recovers rapidly after the surgery. The patient is able to walk on the same day as surgery, and can be discharged within 3-4 days. The patients initially are put on liquid diet for around 7-10 days after the surgery and slowly they change it to soft of semi-solid for another 2 weeks. The weight loss is slow and gradual as desired. A patient loses 4-5 kgs. on monthly basis initially after the surgery. Most patients are able to lose around 40-45 kg over a period of one year. Weightloss is not the only solution for a successful surgery. This surgery positively impacts a number of associated diseases. The result on diabetes is most impactful. Most patients don’t need any diabetes medication soon after the surgery is done. In fact, if they are given the anti-diabetic medication, the blood sugars can become very low.

 Such great and fast effect on diabetes after the surgery has helped grow enthusiasm for possible cure of diabetes through surgery even for patients who are moderately obese (BMI 30-35). Other diseases like high blood pressure, asthma, joint disease, sleep apnea, depression etc also show a significant improvement over a longer period of time.

Bariatric surgery results in considerable weight loss, which helps in improving the quality of life. Patients who used find it difficult to walk even few steps prior to the surgery are able to walk a substantial distance after losing weight. One of the myths is that surgery leads to weakness. Nothing could be beyond the truth. The patients who have undergone bariatric surgery have a better quality of life, are more active, and require less medical care.

 The weight loss surgery or bariatric surgery includes various types of procedures or surgeries. The cost of these types of weight loss surgeries may differ depending upon the procedure and hospital. In India, the cost of weight loss surgery ranges from Rs. 2,25,000 to Rs.7,00,000. The bariatric surgery cost in India may be different in different cities. It depends on the surgeon, hospital, and type of bariatric surgery favored or suggested by the doctor as per the BMI (Body Mass Index) of the patient.

 The success rate of bariatric surgery is majorly depended upon the surgeon and the patient. The type of surgery performed, the patient’s fulfilment with the dietetic advice and lifestyle modifications can bring a huge difference in results.

[databridgemarketresearchblog]

Global Gastric Cancer Drug Market Size to Grow at a Steady Rate During Forecast Period 2026

Market Analysis: Global Gastric Cancer Drug Market

Global gastric cancer drug market is rising gradually to an estimated value of USD 4.37 billion by 2026 registering a substantial CAGR of 9.6% in the forecast period of 2019-2026. This rise in market value can be attributed vulnerable aging population, robust drug pipeline and people adopting unhealthy lifestyle.

Few of the major competitors currently working in the gastric cancer drug market are, Imugene Limited ,  Otsuka Pharmaceuticals Co., Ltd , Immutep , F. Hoffmann-La Roche Ltd ,   Merck KGaA ,  Bristol-Myers Squibb Company , Novartis AG , Eli Lilly and Company , Sanofi S.A , Amgen Inc., Bayer AG, Celgene Corporation, Gilead Sciences, Inc., AstraZeneca, Ipsen Pharma, Takeda Pharmaceutical Company Limited, Samumed, LLC, Arbutus Biopharma, ASLAN Pharmaceuticals  and among others.

Get Sample Analysis of Global Market Information: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-gastric-cancer-drug-market

Market Definition: Global Gastric Cancer Drug Market

The gastric cancer drug refers to malignant tumors that begin in the lining of the stomach. This gastric cancer tends to develops over many years. It usually goes undiagnosed since it does not cause any early symptoms.

According to the article published in World Cancer Research Fund, it is identified gastric cancer was responsible for fourth most common malignancy occur in men and seventh rank in women. It is estimated that over 1.00 million new cases seen in the 2018. The high rate of incidence cases occurs in the South Korea in year of 2018. Advances in available medication, accelerating demand of novel therapies and increasing number of gastric related cancer are the drivers to the market.

Market Drivers

Increase in prevalence rate of gastric cancer due to lifestyle changes

Chronic consumption of tobacco products and alcohol

Adopting an unhealthy lifestyle such as diet with high fat, spicy food, less proteins consumption and physical inactivity

Increase in obesity cases are anticipated to the result of occurrence of gastric cancer

Rising awareness about treatment and technological advancement is driving the growth of market

Increase in the rate of R&D initiatives is driving gastric cancer drug market

Market Restraints

High cost involved in the treatment

Patent expiry from many companies and introduction of generic drugs is expected to restrain the growth if the market

Segmentation: Global Gastric Cancer Drug Market

By Type

Adenocarcinoma

Lymphoma

Gastrointestinal stromal tumor

Carcinoid tumor

Others

By Drug Type

Doxorubicin Hydrochloride

Sunitinib

Mitomycin

Imatinib

Fluorouracil

Trastuzumab

Docetaxel

Others

By Treatment

Medication

Chemotherapy

Targeted Therapy

Radiation Therapy

Immunotherapy

Surgery

By Route of administration

Oral

Injectable

By End users

Hospitals

Homecare

Specialty Clinics

Others

By Geography

North America

South America

Europe

Asia-Pacific

Middle East & Africa

U.S.

Canada

Mexico

Brazil

Argentina

Rest of South America

Germany

France

United Kingdom

Italy

Spain

Russia

Turkey

Belgium

Netherlands

Switzerland

Rest of Europe

Japan

China

South Korea

India

Australia

Singapore

Thailand

Malaysia

Indonesia

Philippines

Rest of Asia-Pacific

South Africa

Egypt

Saudi Arabia

United Arab Emirates

Israel

Rest of Middle East & Africa

Get TOC of Full Report: https://www.databridgemarketresearch.com/toc/?dbmr=global-gastric-cancer-drug-market

Key Developments in the Market:

On February 2019, Taiho Pharmaceutical Co., Ltd as a subsidiary of Otsuka Holdings Co., Ltd received FDA approval for Lonsurf (trifluridine/tipiracil, TAS-102) for the treatment of patient with advanced or metastatic gastric cancer, which was previously administered on first line chemotherapy

On September 2017, Merck & Co., Inc. received accelerated approval from FDA for Keytruda (pembrolizumab) for the treatment of patient with locally advanced or metastatic, gastric or gastro-oesophageal junction adenocarcinoma

Competitive Analysis: Global Gastric Cancer Drug Market

Global gastric cancer drug market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of cystic fibrosis market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa